Evidence map›Paper›PMID 38030482›Full record

ReviewTrends in endocrinology and metabolism: TEM2024

Methylmalonic acid in aging and disease.

Joanne Tejero, Felicia Lazure, Ana P Gomes

Open access · greenAbstract readReview
In one paragraph

Review in Trends in endocrinology and metabolism: TEM, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Joanne TejeroDepartment of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA; Department of Molecular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL 33612, USA.
Felicia LazureDepartment of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
Ana P GomesDepartment of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA. Electronic address: ana.dasilvagomes@moffitt.org.
Moffitt Cancer Center · USUniversity of South Florida · US

Funding

AGING AS A SELECTIVE PRESSURE THAT DRIVES TUMOR PROGRESSIONDP2AG077698 · NIA · H. LEE MOFFITT CANCER CTR & RES INST · PI DA SILVA GOMES, ANA · 2021 to 2024
$2.5M
Vitamin B12 supplementation as novel therapeutic strategy to improve cancer-associated outcomesR00CA218686 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI DA SILVA GOMES, ANA · 2020 to 2022
$916k
Adaptations of breast cancer metastasis to the aging lungR21AG083720 · NIA · H. LEE MOFFITT CANCER CTR & RES INST · PI DA SILVA GOMES, ANA · 2023 to 2024
$463k
NCI NIH HHS R00 CA218686NIA NIH HHS DP2 AG077698NIA NIH HHS R21 AG083720
6 · The paper itself

Abstract

Metabolic byproducts have conventionally been disregarded as waste products without functions. In this opinion article, we bring to light the multifaceted role of methylmalonic acid (MMA), a byproduct of the propionate metabolism pathway mostly commonly known as a clinical biomarker of vitamin B12 deficiency. MMA is normally present at low levels in the body, but increased levels can come from different sources, such as vitamin B12 deficiency, genetic mutations in enzymes related to the propionate pathway, the gut microbiota, and aggressive cancers. Here, we describe the diverse metabolic and signaling functions of MMA and discuss the consequences of increased MMA levels, such as during the aging process, for several age-related human pathologies.

Indexed as

Vitamin B 12Vitamin B 12 DeficiencyAgingHumansMethylmalonic AcidPropionatesMethylmalonic AcidPropionatesVitamin B 12agingdiseasemetabolismmethylmalonic acid

Identifiers

PMID38030482
PMCPMC10939937
OpenAlexW4389101595

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.